Events: May 12, 2017
Serving through technology: UWM-SOIS students visit Red Arrow Labs
When given the opportunity to encourage future technologists to make an impact on the world, we say yes! A few weeks ago, Red Arrow had the privilege to mentor a small group of students from the UWM School of Information Studies (SOIS), by providing feedback on their website project designed for a local non-profit.
News: May 8, 2017
Dohmen announces new Vice President, Contracting and Payer Access, DLSS
Dohmen has appointed Brian Davis as its new Vice President of Contracting and Payer Access for orphan drug manufacturers for Dohmen Life Science Services.
Events: March 31, 2017
Let's Battle! Red Arrow sponsors tomorrow's generation of innovation
At Red Arrow, we get excited about ideas. But, we get thrilled when ideas turn into action. For us, it’s not just about creating transformative software for life science and health companies. It’s also about transforming and supporting tomorrow’s generation of leaders. That’s why we joined hundreds of students and spectators recently at the FIRS...
News: March 31, 2017
Dohmen's high-touch patient support model featured in PharmaVOICE
A recent issue of PharmaVOICE highlights how the integrated model for rare disease patient support helps improve therapy adherence and build better patient relationships.
Events: March 3, 2017
Celebrating G.I.R.L.S and inspiring the next generation of tech leaders
When you are passionate about making a difference in the community where you work and live, you take part in opportunities like the Boys & Girls Club of Greater Milwaukee’s Celebrating G.I.R.L.S event.
News: February 27, 2017
Dohmen unveils infographic recognizing importance of Rare Disease Day 2017
This week Dohmen Life Science Services joins millions of people in recognition of Rare Disease Day on February 28 – a worldwide effort to raise awareness for the patients and caregivers impacted by rare disease every day.
News: February 20, 2017
Dohmen releases new white paper on improved outsourcing model for orphan drug manufacturers
The $114 billion orphan drug industry is traditionally served by a multi-channel model of disparate service providers. Each claims expertise in a specific niche of services, yet therapy adherence for rare disease patients is just over 58 percent. The Dohmen Life Science Services white paper explores an integrated outsourcing model that’s dri...
Events: January 17, 2017
Dohmen welcomes Boys & Girls Club of Greater Milwaukee to Red Arrow Labs
The Dohmen Company is proud to participate in the Boys & Girls Club of Greater Milwaukee’s “Celebrating GIRLS” campaign.
News: December 21, 2016
Dohmen leaders named to BioForward Board of Directors, poised to spark more innovation in Wisconsin
Showcasing Dohmen’s commitment to growing the life sciences sector in Wisconsin, today BioForward, the state’s growing biohealth industry association, named Dohmen leaders to its Board of Directors. Eric Floyd, Ph.D., MBA, Chief Science Officer for Dohmen Life Science Services was appointed for the 2017-19 term. Floyd joins Joe Hammer, Dohmen’s ...
News: December 20, 2016
Dohmen’s Wendy White named Global Genes Chairman of the Board
Global Genes, one of the world’s leading nonprofit rare disease patient advocacy organizations, recently named Wendy White, Dohmen Life Science Services (DLSS) Senior Vice President, Rare Disease, as the Chairman of the Board.